Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in antimicrobial therapy.

A T Pavia1

  • 1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City 84132, USA.

Seminars in Pediatric Neurology
|January 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex PCR-based detection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families.

Clinical nephrology·2003
Same author

Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2002
Same author

Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?

Pediatrics·2001
Same author

Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak.

Pediatrics·2000
Same author

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.

JAMA·2000

Newer antimicrobial agents offer hope against antibiotic-resistant central nervous system (CNS) pathogens. This review details advancements in treating complex CNS infections caused by evolving resistant bacteria.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Neuroscience

Background:

  • Infectious pathogens continue to cause significant global morbidity and mortality.
  • Antibiotic resistance in common infectious agents presents a major medical challenge.
  • Effective treatments for central nervous system (CNS) infections are crucial.

Purpose of the Study:

  • To review the current status of novel antimicrobial agents.
  • To identify agents with efficacy against CNS pathogens.
  • To address the challenge of antibiotic resistance in CNS infections.

Main Methods:

  • Literature review of recent studies on antimicrobial agents.
  • Analysis of antimicrobial efficacy against CNS pathogens.
  • Focus on agents targeting resistant infectious agents.

Related Experiment Videos

Main Results:

  • Several new antimicrobial agents show promise for treating CNS infections.
  • Emerging therapies are being developed to combat antibiotic resistance.
  • The review highlights agents effective against specific resistant CNS pathogens.

Conclusions:

  • Novel antimicrobial agents are vital for managing antibiotic-resistant CNS infections.
  • Continued research is needed to combat evolving resistance patterns.
  • Advancements in antimicrobial therapy are critical for improving patient outcomes in CNS infections.